Caregivers: Being a ‘care partner’ for someone is not a burden
Being a caregiver for someone with Parkinson’s disease can be difficult, but for family members, providing care is…
Articles by Marisa Wexler, MS
Study challenges use of KTP as potential treatment for Parkinson’s
A new study by scientists in Australia may be set to overturn more than a decade of thinking that the…
‘Game changer’ of new system proposed for classifying Parkinson’s
Scientists have proposed a new way to classify Parkinson’s disease based on biological changes associated with the disorder. “Without…
ProMIS moving ahead with vaccine against toxic alpha-synuclein
ProMIS Neurosciences announced arriving at a lead candidate vaccine against the misfolded alpha-synuclein protein, which the company plans…
Air pollution amplifies Parkinson’s risk when genetics also a factor
Air pollution may increase the risk of Parkinson’s disease, particularly in people who are already genetically predisposed to develop…
Easy-to-use inhaled levodopa system readying request for US approval
Levodopa Cyclops, an inhaled version of levodopa that PureIMS is developing as a treatment for off episodes with…
Test in development aims to spot tiny alpha-synuclein fibrils early
A new test that can detect extremely small concentrations of clumped alpha-synuclein may help to detect Parkinson’s disease and…
FDA approves new DBS device from Medtronic
The U.S. Food and Drug Administration (FDA) has approved Medtronic‘s Percept RC deep brain stimulation (DBS) system, clearing it…
Implantable device gives electrical stimulation without battery
Scientists have created an implantable device that can provide electrical stimulation in the body without need for a battery. The…
Afzelin, a plant compound, shows neuroprotective potential in study
A plant compound called afzelin lessened motor abnormalities in a rat model of Parkinson’s disease, a study reports. Afzelin,…